Zhende Medical Co., Ltd. (SHA:603301)
China · Delayed Price · Currency is CNY 91.00
+1.74 (1.95%)
Jul 31, 2026, 3:00 PM CST
Zhende Medical Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4,338 | 4,330 | 4,264 | 4,127 | 6,138 | 5,092 |
Revenue Growth | 1.09% | 1.54% | 3.32% | -32.76% | 20.54% | -51.04% |
Gross Profit Gross Profit Growth | 1,437 | 1,431 | 1,414 | 1,277 | 2,075 | 1,738 |
Operating Income Operating Income Growth | 328.29 | 326.11 | 375.05 | 233.3 | 812.89 | 727.2 |
Net Income Net Income Growth | 264.02 | 260.82 | 385.17 | 198.4 | 679.88 | 595.86 |
Earnings Per Share EPS Growth | 1.00 | 0.99 | 1.45 | 0.74 | 2.87 | 2.63 |
EPS Growth | -26.32% | -31.72% | 95.95% | -74.22% | 9.13% | -78.96% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Basic Care Basic Care Growth | 878.34 |
Surgical Infection Control Surgical Infection Control Growth | 1,876 |
Compression Therapy and Immobilization Compression Therapy and Immobilization Growth | 487.42 |
Ostomy and Modern Wound Care Ostomy and Modern Wound Care Growth | 758.28 |
Infection Control Protection Infection Control Protection Growth | 306.11 |
Other Other Growth | 23.05 |
Total Total Growth | 4,330 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,069 | 1,109 | 828.39 | 1,207 | 2,175 | 1,364 |
Total Debt Total Debt Growth | 1,288 | 1,282 | 588.17 | 636.92 | 605.85 | 848.36 |
Net Cash (Debt) Net Cash Growth | -219.04 | -173.59 | 240.22 | 570.5 | 1,569 | 515.16 |
Net Cash Growth | - | - | -57.89% | -63.64% | 204.55% | -72.27% |
Net Cash Per Share Net Cash Per Share Growth | -0.83 | -0.66 | 0.90 | 2.13 | 6.62 | 2.27 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 572.01 | 538.49 | 461.14 | 452.11 | 1,246 | 817.63 |
Capital Expenditures CapEx Growth | -431.33 | -550.22 | -769.69 | -599.24 | -754.12 | -695.47 |
Free Cash Flow Free Cash Flow Growth | 140.68 | -11.73 | -308.55 | -147.13 | 491.92 | 122.16 |
Free Cash Flow Growth | - | - | - | - | 302.68% | -93.98% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 33.12% | 33.05% | 33.16% | 30.93% | 33.80% | 34.14% |
Operating Margin | 7.57% | 7.53% | 8.80% | 5.65% | 13.24% | 14.28% |
Pretax Margin | 7.58% | 7.50% | 11.15% | 5.30% | 13.06% | 16.10% |
Profit Margin | 6.09% | 6.02% | 9.03% | 4.81% | 11.08% | 11.70% |
FCF Margin | 3.24% | -0.27% | -7.24% | -3.56% | 8.02% | 2.40% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.300 | 0.300 | 0.650 | 1.250 | - | 0.600 |
Dividend Per Share Growth | -53.85% | -53.85% | -48.00% | - | - | -73.91% |
Dividend Yield | 0.33% | 0.43% | 3.06% | 5.41% | - | 1.33% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 91.02 | 71.82 | 15.21 | 32.64 | 14.80 | 19.41 |
Forward PE | 48.92 | 42.34 | 12.67 | 9.13 | 11.70 | 18.82 |
P/FCF Ratio | 170.61 | - | - | - | 20.45 | 94.66 |
PS Ratio | 5.53 | 4.33 | 1.37 | 1.57 | 1.64 | 2.27 |